NIR-mbc94, a fluorescent ligand that binds to endogenous cB2 receptors and is amenable to high-throughput screening

Chemistry and Biology

Volumn 18, Issue 5, 2011, Pages 563-568

  Sexton, Michelle ^a   Woodruff, Grace ^b   Horne, Eric A ^a   Lin, Yi Hsing ^a   Muccioli, Giulio G ^c   Bai, Mingfeng ^d   Stern, Eric ^e   Bornhop, Darryl J ^e   Stella, Nephi ^a,b  

^a UNIVERSITY OF WASHINGTON SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF WASHINGTON   (United States)

^c UNIVERSITÉ CATHOLIQUE DE LOUVAIN   (Belgium)

^d UNIVERSITY OF PITTSBURGH MEDICAL CENTER   (United States)

^e VANDERBILT UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CANNABINOID 2 RECEPTOR; FLUORESCENT DYE; NIR MBC94; NIR-MBC94; NORBORNANE DERIVATIVE; PYRAZOLE DERIVATIVE;

ANIMAL; ARTICLE; CHEMISTRY; DRUG ANTAGONISM; HIGH THROUGHPUT SCREENING; INVERSE AGONISM; METABOLISM; MOUSE; PROTEIN BINDING; TUMOR CELL LINE;

ANIMALS; CELL LINE, TUMOR; DRUG INVERSE AGONISM; FLUORESCENT DYES; HIGH-THROUGHPUT SCREENING ASSAYS; MICE; NORBORNANES; PROTEIN BINDING; PYRAZOLES; RECEPTOR, CANNABINOID, CB2;

EID: 79957469883     PISSN: 10745521     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.chembiol.2011.02.016     Document Type: Article

References (24)

1. S. Achilefu Introduction to concepts and strategies for molecular imaging Chem. Rev. 110 2010 2575 2578
2. M. Bai, M. Sexton, N. Stella, and D.J. Bornhop MBC94, a conjugable ligand for cannabinoid CB 2 receptor imaging Bioconjug. Chem. 19 2008 988 992 (Pubitemid 351748305)
3. R.B. Banati Neuropathological imaging: in vivo detection of glial activation as a measure of disease and adaptive change in the brain Br. Med. Bull. 65 2003 121 131 (Pubitemid 36406461)
4. N.E. Buckley The peripheral cannabinoid receptor knockout mice: an update Br. J. Pharmacol. 153 2008 309 318
5. G.J. Ciambrone, V.F. Liu, D.C. Lin, R.P. McGuinness, G.K. Leung, and S. Pitchford Cellular dielectric spectroscopy: a powerful new approach to label-free cellular analysis J. Biomol. Screen. 9 2004 467 480
6. E. Cudaback, W. Marrs, T. Moeller, and N. Stella The expression level of CB1 and CB2 receptors determines their efficacy at inducing apoptosis in astrocytomas PLoS ONE 5 2010 e8702
7. B.T. Cunningham, P. Li, S. Schulz, B. Lin, C. Baird, J. Gerstenmaier, C. Genick, F. Wang, E. Fine, and L. Laing Label-free assays on the BIND system J. Biomol. Screen. 9 2004 481 490
8. P. Diagaradjane, J.M. Orenstein-Cardona, N.E. Colon-Casasnovas, A. Deorukhkar, S. Shentu, N. Kuno, D.L. Schwartz, J.G. Gelovani, and S. Krishnan Imaging epidermal growth factor receptor expression in vivo: pharmacokinetic and biodistribution characterization of a bioconjugated quantum dot nanoprobe Clin. Cancer Res. 14 2008 731 741 (Pubitemid 351231154)
9. W. Du, Y. Wang, Q. Luo, and B.F. Liu Optical molecular imaging for systems biology: from molecule to organism Anal. Bioanal. Chem. 386 2006 444 457 (Pubitemid 44450926)
10. W.B. Edwards, B. Xu, W. Akers, P.P. Cheney, K. Liang, B.E. Rogers, C.J. Anderson, and S. Achilefu Agonist-antagonist dilemma in molecular imaging: evaluation of a monomolecular multimodal imaging agent for the somatostatin receptor Bioconjug. Chem. 19 2008 192 200 (Pubitemid 351213851)
11. J. Fernandez-Ruiz, J. Romero, G. Velasco, R.M. Tolon, J.A. Ramos, and M. Guzman Cannabinoid CB2 receptor: a new target for controlling neural cell survival? Trends Pharmacol. Sci. 28 2007 39 45 (Pubitemid 46038536)
12. M. Guzmán Cannabinoids: potential anticancer agents Nat. Rev. Cancer 3 2003 745 755 (Pubitemid 37328813)
13. E. Kostenis, M. Waelbroeck, and G. Milligan Techniques: promiscuous Galpha proteins in basic research and drug discovery Trends Pharmacol. Sci. 26 2005 595 602 (Pubitemid 41505228)
14. M.C. Lagerstrom, and H.B. Schioth Structural diversity of G protein-coupled receptors and significance for drug discovery Nat. Rev. Drug Discov. 7 2008 339 357
15. M. Leopoldo, E. Lacivita, F. Berardi, and R. Perrone Developments in fluorescent probes for receptor research Drug Discov. Today 14 2009 706 712
16. V. Ntziachristos, C. Bremer, and R. Weissleder Fluorescence imaging with near-infrared light: new technological advances that enable in vivo molecular imaging Eur. Radiol. 13 2003 195 208 (Pubitemid 36790510)
17. E.D. Ponomarev, K. Maresz, Y. Tan, and B.N. Dittel CNS-derived interleukin-4 is essential for the regulation of autoimmune inflammation and induces a state of alternative activation in microglial cells J. Neurosci. 27 2007 10714 10721 (Pubitemid 47535871)
18. M. Rinaldi-Carmona, F. Barth, J. Millan, J.M. Derocq, P. Casellas, C. Congy, D. Oustric, M. Sarran, M. Bouaboula, and B. Calandra SR 144528, the first potent and selective antagonist of the CB2 cannabinoid receptor J. Pharmacol. Exp. Ther. 284 1998 644 650 (Pubitemid 28086654)
19. M. Sexton, G. Woodruff, E. Cudaback, F.R. Kreitzer, C. Xu, Y.H. Lin, T. Moller, M. Bai, H.C. Manning, and D. Bornhop Binding of NIR-conPK and NIR-6T to astrocytomas and microglial cells: evidence for a protein related to TSPO PLoS ONE 4 2009 e8271
20. N. Stella Endocannabinoid signaling in microglial cells Neuropharm 56 Suppl 1 2009 244 253
21. N. Stella Cannabinoid and cannabinoid-like receptors in microglia, astrocytes, and astrocytomas Glia 58 2010 1017 1030
22. G.A. Thakur, R. Tichkule, S. Bajaj, and A. Makriyannis Latest advances in cannabinoid receptor agonists Expert Opin. Ther. Pat. 19 2009 1647 1673
23. L. Toll Intact cell binding and the relation to opioid activities in SH-SY5Y cells J. Pharmacol. Exp. Ther. 273 1995 721 727
24. L. Walter, A. Franklin, A. Witting, C. Wade, Y. Xie, G. Kunos, K. Mackie, and N. Stella Non-psychotropic cannabinoid receptors regulate microglial cell migration J. Neurosci. 23 2003 1398 1405 (Pubitemid 36258918)